The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 5489-5497

  Ozaki, Akemi ^a   Seki, Yoh Ichi ^a   Fakushima, Atsuki ^b   Kubo, Masato ^a,c  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 5; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL TRANSFER; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PRURITUS; TH2 CELL; TRANSGENIC MOUSE;

EID: 26844503986     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.5489     Document Type: Article

References (40)

1. Durham, S. R. 1998. The inflammatory nature of allergic disease. Clin. Exp. Allergy 28(Suppl. 6): 20-24.
2. Bacon, A. S., P. Ahluwalia, A. M. Irani, L. B. Schwartz, S. T. Holgate, M. K. Church, and J. I. McGill. 2000. Tear and conjunctival changes during the allergen-induced early- and late-phase responses. J. Allergy Clin. Immunol. 106: 948-954.
3. Fukushima, A., A. Ozaki, K. Fukata, W. Ishida, and H. Ueno. 2003. Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis. Invest. Ophthalmol. Vis. Sci. 44: 4366-4374.
4. Ozaki, A., A. Fukushima, K. Fukata, and H. Ueno. 2003. Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharocon-junctivitis. Graefes Arch. Clin. Exp. Ophthalmol. 241: 394-402.
5. Ozaki, A., A. Fukushima, K. Fukata, and H. Ueno. 2000. Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats. Clin. Exp. Immunol. 122: 28-34.
6. Iwamoto, H., K. Nishino, T. M. Magone, S. M. Whitcup, O. Yoshida, H. Yoshida, A. Ozaki, A. Fukushima, and H. Ueno. 2000. Experimental immune-mediated blepharoconjunctivitis in rats induced by immunization with ragweed pollen. Graefes Arch. Clin. Exp. Ophthalmol. 238: 346-351.
7. Neurath, M. F., S. Finotto, and L. H. Glimcher. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8: 567-573.
8. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
9. O'Byrne, P. M., M. D. Inman, and E. Adelroth. 2004. Reassessing the Th2 cytokine basis of asthma. Trends Pharmacol. Sci. 25: 244-248.
10. Leckie, M. J., A. ten Brinke, J. Khan, Z. Diamant, B. J. O'Connor, C. M. Walls, A. K. Mathur, H. C. Cowley, K. F. Chung, R. Djukanovic, et al. 2000. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356: 2144-2148.
11. Magone, M. T., S. M. Whitcup, A. Fukushima, C. C. Chan, P. B. Silver, and L. V. Rizzo. 2000. The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis. J. Allergy Clin. Immunol. 105: 299-308.
12. Inoue, H., and M. Kubo. 2004. SOCS proteins in T helper cell differentiation: implications for allergic disorders? Expert Rev. Mol. Med. 6: 1-11.
13. Alexander, W. S., and D. J. Hilton. 2004. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22: 503-529.
14. Kubo, M., T. Hanada, and A. Yoshimura. 2003. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4: 1169-1176.
15. Croker, B. A., D. L. Krebs, J. G. Zhang, S. Wormald, T. A. Willson, E. G. Stanley, L. Robb, C. J. Greenhalgh, I. Forster, B. E. Clausen, et al. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4: 540-545.
16. Berlato, C., M. A. Cassatella, I. Kinjyo, L. Gatto, A. Yoshimura, and F. Bazzoni. 2002. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168: 6404-6411.
17. h2-mediated allergic responses. Nat. Med. 9: 1047-1054.
18. Seki, Y., K. Hayashi, A. Matsumoto, N. Seki, J. Tsukada, J. Ransom, T. Naka, T. Kishimoto, A. Yoshimura, and M. Kubo. 2002. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc. Natl. Acad. Sci. USA 99: 13003-13008.
19. Brender, C., R. Columbus, D. Metcalf, E. Handman, R. Starr, N. Huntington, D. Tarlinton, N. Odum, S. E. Nicholson, N. A. Nicola, et al. 2004. SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function. Mol. Cell. Biol. 24: 6094-6103.
20. Broide, D. H. 2001. Molecular and cellular mechanisms of allergic disease. J. Allergy Clin. Immunol. 108: S65-S71.
21. Tomkinson, A., C. Duez, G. Cieslewicz, J. C. Pratt, A. Joetham, M. C. Shanafelt, R. Gundel, and E. W. Gelfand. 2001. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol. 166: 5792-5800.
22. Agnello, D., C. S. Lankford, J. Bream, A. Morinobu, M. Gadina, J. J. O'Shea, and D. M. Frucht. 2003. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23: 147-161.
23. Kaplan, M. H., and M. J. Grusby. 1998. Regulation of T helper cell differentiation by STAT molecules. J. Leukocyte Biol. 64: 2-5.
24. Ozaki, A., W. Ishida, K. Fukata, A. Fukushima, and H. Ueno. 2004. Detection of antigen-specific T cells in experimental immune-mediated blepharoconjunctivitis in DO11.10 T cell receptor transgenic mice. Microbiol. Immunol. 48: 39-48.
25. Kawamoto, T., and M. Shimizu. 2000. A method for preparing 2- to 50-micron-thick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem. Cell. Biol. 113: 331-339.
26. Sudowe, S., V. Arps, T. Vogel, and E. Kolsch. 2000. The role of interleukin-4 in the regulation of sequential isotype switch from immunoglobulin G1 to immunoglobulin E antibody production. Scand. J. Immunol. 51: 461-471.
27. Coffman, R. L., J. Ohara, M. W. Bond, J. Carty, A. Zlotnik, and W. E. Paul. 1986. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136: 4538-4545.
28. Venge, J., M. Lampinen, L. Hakansson, S. Rak, and P. Venge. 1996. Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J. Allergy Clin. Immunol. 97: 1110-1115.
29. Walter, D. M., J. J. McIntire, G. Berry, A. N. McKenzie, D. D. Donaldson, R. H. DeKruyff, and D. T. Umetsu. 2001. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167: 4668-4675.
30. Borish, L. C., H. S. Nelson, J. Corren, G. Bensch, W. W. Busse, J. B. Whitmore, and J. M. Agosti. 2001. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J. Allergy Clin. Immunol. 107: 963-970.
31. Borish, L. C., H. S. Nelson, M. J. Lanz, L. Claussen, J. B. Whitmore, J. M. Agosti, and L. Garrison. 1999. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 160: 1816-1823.
32. Kips, J. C., B. J. O'Connor, S. J. Langley, A. Woodcock, H. A. Kerstjens, D. S. Postma, M. Danzig, F. Cuss, and R. A. Pauwels. 2003. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am. J. Respir. Crit. Care Med. 167: 1655-1659.
33. Kung, T. T., B. Luo, Y. Crawley, C. G. Garlisi, K. Devito, M. Minnicozzi, R. W. Egan, W. Kreutner, and R. W. Chapman. 2001. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am. J. Respir. Cell Mol. Biol. 25: 600-605.
34. Levitt, R. C., M. P. McLane, D. MacDonald, V. Ferrante, C. Weiss, T. Zhou, K. J. Holroyd, and N. C. Nicolaides. 1999. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J. Allergy Clin. Immunol. 103: S485-S491.
35. Zuany-Amorim, C., S. Haile, D. Leduc, C. Dumarey, M. Huerre, B. B. Vargaftig, and M. Pretolani. 1995. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95: 2644-2651.
36. Kumar, R. K., C. Herbert, D. C. Webb, L. Li, and P. S. Foster. 2004. Effects of anticytokine therapy in a mouse model of chronic asthma. Am. J. Respir. Crit. Care Med. 170: 1043-1048.
37. Yagi, R., H. Nagai, Y. Iigo, T. Akimoto, T. Arai, and M. Kubo. 2002. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J. Immunol. 168: 2020-2027.
38. Uchio, E., S. Y. Ono, Z. Ikezawa, and S. Ohno. 2000. Tear levels of interferon-γ, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin. Exp. Allergy 30: 103-109.
39. O'Garra, A., and N. Arai. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10: 542-550.
40. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2: 665-675.